Literature DB >> 28123986

Multidisciplinary pulmonary embolism response teams and systems.

Peter P Monteleone1, Kenneth Rosenfield1, Rachel P Rosovsky2.   

Abstract

Pulmonary embolism (PE) is a complex diagnosis that encompasses a wide range of clinical presentations. Often patients who present with PE have complicated medical histories which can make their management challenging. Many novel therapeutic strategies and tools are emerging to improve the care and outcomes of patients with PE. Pulmonary embolism response teams (PERTs) are developing at multiple centers to improve the decision making, efficiency and orchestration of these clinical strategies. Concordantly with development of PERT programs is the design and implementation of systems to allow for numerous specialists to convene and discuss complex PE patients in real time. The mechanisms to engage a multidisciplinary approach are proving to be an invaluable resource in the decision making processes and treatment of high risk PE patients. Ultimately, other multi-disciplinary teams may adopt these methods to better address their clinical needs.

Entities:  

Keywords:  Pulmonary embolism (PE); catheter directed thrombolysis (CDT); deep vein thrombosis (DVT); multidisciplinary; pulmonary embolism response team (PERT); rapid response team; thrombolysis; thrombosis

Year:  2016        PMID: 28123986      PMCID: PMC5220194          DOI: 10.21037/cdt.2016.11.05

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  11 in total

1.  Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options.

Authors:  Gregory S Ahearn; Denis Hadjiliadis; Joseph A Govert; Victor F Tapson
Journal:  Arch Intern Med       Date:  2002-06-10

Review 2.  Multidisciplinary Pulmonary Embolism Response Teams.

Authors:  David M Dudzinski; Gregory Piazza
Journal:  Circulation       Date:  2016-01-05       Impact factor: 29.690

3.  A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.

Authors:  Gregory Piazza; Benjamin Hohlfelder; Michael R Jaff; Kenneth Ouriel; Tod C Engelhardt; Keith M Sterling; Noah J Jones; John C Gurley; Rohit Bhatheja; Robert J Kennedy; Nilesh Goswami; Kannan Natarajan; John Rundback; Immad R Sadiq; Stephen K Liu; Narinder Bhalla; M Laiq Raja; Barry S Weinstock; Jacob Cynamon; Fakhir F Elmasri; Mark J Garcia; Mark Kumar; Juan Ayerdi; Peter Soukas; William Kuo; Ping-Yu Liu; Samuel Z Goldhaber
Journal:  JACC Cardiovasc Interv       Date:  2015-08-24       Impact factor: 11.195

4.  The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism.

Authors:  Tim Provias; David M Dudzinski; Michael R Jaff; Kenneth Rosenfield; Richard Channick; Joshua Baker; Ido Weinberg; Cameron Donaldson; Rajeev Narayan; Andrew N Rassi; Christopher Kabrhel
Journal:  Hosp Pract (1995)       Date:  2014-02

5.  Online network of subspecialty aortic disease experts: Impact of "cloud" technology on management of acute aortic emergencies.

Authors:  Paul Schoenhagen; Eric E Roselli; C Martin Harris; Matthew Eagleton; Venu Menon
Journal:  J Thorac Cardiovasc Surg       Date:  2016-03-02       Impact factor: 5.209

Review 6.  Venous thromboembolism: disease burden, outcomes and risk factors.

Authors:  J A Heit
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

Review 7.  Percutaneous treatment of patent foramen ovale and atrial septal defects.

Authors:  Jonathan Tobis; Michael Shenoda
Journal:  J Am Coll Cardiol       Date:  2012-10-03       Impact factor: 24.094

8.  A Multidisciplinary Pulmonary Embolism Response Team: Initial 30-Month Experience With a Novel Approach to Delivery of Care to Patients With Submassive and Massive Pulmonary Embolism.

Authors:  Christopher Kabrhel; Rachel Rosovsky; Richard Channick; Michael R Jaff; Ido Weinberg; Thoralf Sundt; David M Dudzinski; Josanna Rodriguez-Lopez; Blair A Parry; Savanah Harshbarger; Yuchiao Chang; Kenneth Rosenfield
Journal:  Chest       Date:  2016-03-19       Impact factor: 9.410

9.  Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.

Authors:  Nils Kucher; Peter Boekstegers; Oliver J Müller; Christian Kupatt; Jan Beyer-Westendorf; Thomas Heitzer; Ulrich Tebbe; Jan Horstkotte; Ralf Müller; Erwin Blessing; Martin Greif; Philipp Lange; Ralf-Thorsten Hoffmann; Sebastian Werth; Achim Barmeyer; Dirk Härtel; Henriette Grünwald; Klaus Empen; Iris Baumgartner
Journal:  Circulation       Date:  2013-11-13       Impact factor: 29.690

Review 10.  Use of thrombolytics for the treatment of thromboembolic disease during pregnancy.

Authors:  M A Turrentine; G Braems; M M Ramirez
Journal:  Obstet Gynecol Surv       Date:  1995-07       Impact factor: 2.347

View more
  4 in total

1.  Advanced venous imaging and image-guided venous interventions.

Authors:  Sasan Partovi; Suvranu Ganguli
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

2.  Pulmonary Embolism: Contemporary Medical Management and Future Perspectives.

Authors:  Stefano Barco; Stavros V Konstantinides
Journal:  Ann Vasc Dis       Date:  2018-09-25

3.  Role of Pulmonary Embolism Response Team in patients with intermediate- and high-risk pulmonary embolism: a concise review and preliminary experience from China.

Authors:  Ying Liang; Shao-Ping Nie; Xiao Wang; Ashley Thomas; Elizabeth Thompson; Guan-Qi Zhao; Jing Han; Jing Wang; Mark J D Griffiths
Journal:  J Geriatr Cardiol       Date:  2020-08       Impact factor: 3.327

4.  Management of a huge right atrial thrombus in a patient with multiple comorbidities.

Authors:  Peter Philip Shaker Selwanos; Ahmed Osman Ahmed; Karim Mohamed El Bakry; Ahmed Nazmy Elsharkawy; Omar Alaaeldin Mohamed; Hatem Hosny; Amir Anwar Shaker Samaan
Journal:  Egypt Heart J       Date:  2020-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.